Zhende Medical(SH:603301) Sou Hu Cai Jing·2025-06-02 21:52Summary of Key Points Core Viewpoint - Zhendemedical (603301) has made significant progress in sustainable development and social responsibility, as highlighted in its 2024 ESG report, while also announcing a loan agreement and an extension of its employee stock ownership plan. Group 1: Trading Information - On May 30, 2025, Zhendemedical's stock closed at 20.83 yuan, with a slight increase of 0.34% and a turnover rate of 0.8% [1] - The trading volume was 21,300 shares, with a total transaction amount of 44.2142 million yuan [1] - The fund flow on the same day showed a net outflow of 3.6882 million yuan from main funds, a net inflow of 4.6381 million yuan from speculative funds, and a net outflow of 949,900 yuan from retail investors [1][4] Group 2: Company Announcements - Zhendemedical released its 2024 Sustainable Development Report, emphasizing governance, employee care, green development, and reliable cooperation, with notable advancements in compliance management and climate change response [2] - The company participated in the EcoVadis rating in 2024 and received a silver medal, while also launching a 2030 carbon pathway plan and committing to the Science Based Targets initiative (SBTi) [2] - Zhendemedical's R&D investment for the year reached 135.49 million yuan, resulting in 9 new Class II medical device registrations and 28 invention patents [2] - The company announced a loan agreement with the International Finance Corporation (IFC) for up to 30 million USD, with a repayment period from 2029 to 2033 [2] - The first employee stock ownership plan has been extended by 6 months until January 2, 2026, due to unliquidated shares [3][5]